医薬政策に関わる情報コンシェルジュ
Pharma Policy Planning P-Cubed

海外医薬品の不足情報・医薬政策情報等を
デイリーで発信中

諸外国不足状況
【毎日更新】

  • 2024.07.16 [ フランス ]
    ステータス (英語)アップデートスペシャルティ
    供給の緊張2024年7月12日パリペリドン・バイオガラン、プレフィルドシリンジ注射用徐放性懸濁液 – [パリペリドン]
    供給の緊張2024年7月12日オドリック-トランドラプリル2mgおよび4mg、カプセル-(トランドラプリル)
    供給の緊張2024年7月12日オンダンセトロン ビアトリス 2mg/ml、注射用液(I.V.)- [オンダンセトロン]
    供給の緊張2024年7月12日プレギゾール、バッグ入り冠動脈内投与用心筋保護液-[カルシウム(塩化物)二水和物/マグネシウム(塩化物)六水和物/カリウム(塩化物)/ナトリウム(塩化物)]
    供給の緊張2024年7月11日アミカシンビアトリス250mg、500mg、注射用粉末バイアル中 – [アミカシン(硫酸塩)
    在庫切れ2024年7月10日マイコスタチン 100 000 IU/ml, 経口懸濁液 – [ナイスタチン]
    在庫切れ2024年7月10日エトポシド・アコード 20mg/ml、輸液用希釈液 – [エトポシド]
    在庫切れ2024年7月9日ファストルテック1.5mg/ml、輸液用希釈液用粉末および溶剤 – [rasburicase]
    在庫切れ2024年7月8日B.A.L.、注射用液I.M. – [ブタカイン-ジメルカプロール]
    在庫切れ2024年7月8日アザクタム1g、非経口用粉末および溶液 – [アズトレオナム]
    在庫切れ2024年7月8日メノパー 75 IU/ml、注射用溶液の粉末および溶剤 – [menotropin]
    在庫切れ2024年7月8日メノピュール600IU/ml、注射用溶液の粉末および溶剤 – [menotropin]
  • 2024.07.16 [ ドイツ ]
    有効成分投与形態理由メッセージタイプ最後のメッセージの日付
    ベバシズマブInfusionsl調製用濃縮液ung生産における問題初回通知12.07.2024
    アモキシシリン三水和物経口懸濁液調製用粉末需要変更通知12.07.2024
    フェノキシメチルペニシリン-ベンザチン経口懸濁液需要初回通知12.07.2024
    フェノキシメチルペニシリンカリウム経口用L製剤用顆粒ung需要変更通知12.07.2024
    アテノロール; クロルタリドンフィルムコート錠需要初回通知12.07.2024
    アジスロマイシン二水和物フィルムコート錠その他変更通知12.07.2024
    アジスロマイシン二水和物経口懸濁液調製用粉末需要変更通知12.07.2024
    アレンドロン酸ナトリウム(Ph.Eur.)フィルムコート錠その他変更通知12.07.2024
    <2>シプロフロキサシン塩酸塩(1:1) 1 H Oフィルムコート錠需要変更通知12.07.2024
    パリカルシトールInjektionslung需要変更通知12.07.2024
    メトホルミン塩酸塩;シタグリプチン塩酸塩一水和物フィルムコート錠その他変更通知11.07.2024
    アルギニン塩酸塩Infusionsl調製用濃縮液ungその他変更通知11.07.2024
    炭酸水素ナトリウム腸溶錠需要初回通知10.07.2024
    ベタメタゾン・バレレート(Ph.Eur.)エマルジョン需要初回通知10.07.2024
    ラベプラゾールナトリウム腸溶錠需要変更通知10.07.2024
    ナロキソン塩酸塩二水和物;オキシコドン塩酸塩(Ph.Eur.)徐放錠生産能力不足変更通知10.07.2024
    セファクロル一水和物ハードカプセル生産能力不足初回通知09.07.2024
    オランザピンエンボン酸一水和物パウダー針の供給問題変更通知09.07.2024
    リセドロン酸ナトリウム-2初回通知09.07.2024
    硫酸サルブタモール加圧ガスの吸入需要変更通知09.07.2024
    塩酸ラニチジンフィルムコート錠その他変更通知09.07.2024
    スルバクタムナトリウム注射剤または輸液用粉末ung需要変更通知09.07.2024
    ピルフェニドン08.07.2024初回通知08.07.2024
    セファクロル一水和物経口懸濁液調製用顆粒その他変更通知08.07.2024
    ジメンヒドリナートInjektionslungその他変更通知08.07.2024
  • 2024.07.16 [ オーストラリア ]
    Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
    galantamine hydrobromideCapsule, modified release20.512 mgCurrentUnavailableManufacturing12/07/2024
    haloperidolInjection, solution5 mg/mLResolvedAvailableManufacturing12/07/2024
    pregabalinCapsule, hard75 mgResolvedAvailableCommercial Changes / Commercial viability12/07/2024
    pregabalinCapsule, hard300 mgResolvedAvailableManufacturing12/07/2024
    emtricitabine~tenofovir disoproxil maleateTablet, film coated200 mg~300 mgCurrentLimited AvailabilityManufacturing12/07/2024
    cinacalcet hydrochlorideTablet, film coated66 mgCurrentUnavailableManufacturing12/07/2024
    cinacalcet hydrochlorideTablet, film coated99 mgCurrentUnavailableManufacturing12/07/2024
    ezetimibe~simvastatinTablet10 mg~20 mgCurrentUnavailableManufacturing12/07/2024
    olmesartan medoxomil~amlodipine besilateTablet, film coated20 mg~6.935 mgCurrentUnavailableManufacturing12/07/2024
    mercaptopurine monohydrateTablet50 mgCurrentLimited AvailabilityManufacturing12/07/2024
    gliclazideTablet, modified release30 mgResolvedAvailableManufacturing12/07/2024
    AdalimumabInjection, solution40 mgDiscontinuedUnavailableCommercial Changes / Commercial viability12/07/2024
    AdalimumabInjection, solution40 mgDiscontinuedUnavailableCommercial Changes / Commercial viability12/07/2024
    carbidopa monohydrate~levodopaTablet, modified release54 mg~200 mgResolvedAvailableManufacturing12/07/2024
    adrenaline (epinephrine)Injection, solution300 microgramDiscontinuedReduction in supply until supply is exhaustedManufacturing12/07/2024
    adrenaline (epinephrine)Injection, solution150 microgramDiscontinuedReduction in supply until supply is exhaustedManufacturing12/07/2024
    lacosamideTablet, film coated50 mgCurrentUnavailableManufacturing12/07/2024
    lacosamideTablet, film coated100 mgResolvedAvailableManufacturing12/07/2024
    prucalopride succinateTablet2.642 mgCurrentUnavailableManufacturing12/07/2024
    sitagliptin hydrochloride monohydrateTablet, film coated27.25 mgCurrentUnavailableManufacturing12/07/2024
    ezetimibe~rosuvastatin calciumTablet10 mg~10.4 mgResolvedAvailableManufacturing12/07/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~20.8 mgResolvedAvailableManufacturing12/07/2024
    octreotideInjection, solution50 microgram/mLCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply12/07/2024
    octreotideInjection, solution100 microgram/mLCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply12/07/2024
    captoprilTablet, uncoated25 mgCurrentUnavailableManufacturing12/07/2024
    idarubicin hydrochlorideInjection, solution1 mg/mLCurrentLimited AvailabilityManufacturing12/07/2024
    tobramycinInhalation, conventional60 mg/mLCurrentUnavailableManufacturing12/07/2024
    carbamazepineTablet, uncoated200 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability12/07/2024
    carbamazepineTablet, uncoated100 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability12/07/2024
    methylphenidate hydrochlorideTablet, modified release54 mgCurrentLimited AvailabilityManufacturing12/07/2024
    hydroxocobalamin chlorideInjection, solution1.027 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues11/07/2024
    varenicline tartrate~varenicline tartrateTablet, film coated.85 mg~1.71 mgCurrentUnavailableManufacturing11/07/2024
    varenicline tartrateTablet, film coated1.71 mgCurrentUnavailableManufacturing11/07/2024
    ondansetron hydrochloride dihydrateTablet, film coated5 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues11/07/2024
    vecuronium bromideInjection, powder for10 mgCurrentLimited AvailabilityUnexpected increase in consumer demand11/07/2024
    carmustineInjection, powder for100 mgCurrentUnavailableManufacturing11/07/2024
    paclitaxelInjection, concentrated300 mgCurrentLimited AvailabilityManufacturing11/07/2024
    modafinilTablet, uncoated100 mgCurrentLimited AvailabilityManufacturing11/07/2024
    montelukast sodiumTablet, chewable5.2 mgCurrentEmergency Supply OnlyManufacturing11/07/2024
    montelukast sodiumTablet, chewable4.16 mgCurrentLimited AvailabilityManufacturing11/07/2024
    estradiolDrug delivery system, transdermal.39 mgCurrentLimited AvailabilityManufacturing11/07/2024
    methotrexateTablet10 mgAnticipatedAvailableManufacturing11/07/2024
    doxorubicin hydrochlorideInjection, concentrated2 mg/mLCurrentUnavailableManufacturing11/07/2024
    potassium clavulanate~amoxicillin trihydrateSuspension, powder for7.45 mg/mL~28.7 mg/mLCurrentLimited AvailabilityManufacturing10/07/2024
    ceftazidime pentahydrateInjection, powder for1.164 gResolvedAvailableManufacturing10/07/2024
    midazolamInjection, solution5 mgResolvedAvailableManufacturing10/07/2024
    diazoxideInjection, solution15 mg/mLResolvedAvailableTransport / Logistic issues / Storage capacity issues10/07/2024
    prochlorperazine maleateTablet5 mgResolvedAvailableCommercial Changes / Commercial viability10/07/2024
    propranolol hydrochlorideTablet, film coated40 mgResolvedAvailableManufacturing10/07/2024
    oxytocinInjection, solution10 IU/mLCurrentUnavailableTransport / Logistic issues / Storage capacity issues10/07/2024
    betahistine dihydrochlorideTablet, uncoated16 mgCurrentUnavailableManufacturing10/07/2024
    tadalafilTablet, film coated5 mgCurrentLimited AvailabilityManufacturing10/07/2024
    tadalafilTablet, film coated20 mgCurrentLimited AvailabilityManufacturing10/07/2024
    betahistine dihydrochlorideTablet, uncoated16 mgCurrentUnavailableManufacturing10/07/2024
    acarboseTablet100 mgCurrentLimited AvailabilityManufacturing10/07/2024
    desvenlafaxine benzoateTablet, modified release73.16 mgCurrentUnavailableManufacturing10/07/2024
    tadalafilTablet, film coated20 mgCurrentUnavailableUnexpected increase in consumer demand10/07/2024
    atorvastatin calcium trihydrate~ezetimibeTablet, film coated41.363 mg~10 mgCurrentUnavailableManufacturing10/07/2024
    nebivolol hydrochlorideTablet5.45 mgCurrentUnavailableManufacturing10/07/2024
    estradiolDrug delivery system, transdermal1.56 mgCurrentLimited AvailabilityManufacturing10/07/2024
    rosuvastatin calciumTablet, film coated5.21 mgCurrentUnavailableManufacturing10/07/2024
    chloramphenicolEye Drops, solution5 mg/mLCurrentUnavailableManufacturing10/07/2024
    paracetamolTablet, modified release665 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues10/07/2024
    naproxenTablet, uncoated250 mgResolvedAvailableManufacturing10/07/2024
    medroxyprogesterone acetateInjection, suspension150 mg/mLDiscontinuedUnavailableCommercial Changes / Commercial viability10/07/2024
    doxorubicin hydrochlorideInjection, concentrated2 mg/mLCurrentLimited AvailabilityManufacturing10/07/2024
    norethisterone acetate~estradiolDrug delivery system, transdermal2.7 mg~.62 mgCurrentUnavailableManufacturing10/07/2024
    calcium folinateInjection324.1 mgAnticipatedAvailableManufacturing9/07/2024
    pentetic acidInjection, powder for5 mgResolvedAvailableManufacturing9/07/2024
    olanzapineTablet, film coated7.5 mgResolvedAvailableManufacturing9/07/2024
    methotrexateInjection, solution2.5 mg/mLResolvedAvailableManufacturing9/07/2024
    metoprolol succinateTablet, modified release190 mgAnticipatedAvailableManufacturing9/07/2024
    metoprolol succinateTablet, modified release95 mgAnticipatedAvailableManufacturing9/07/2024
    pramipexole dihydrochloride monohydrateTablet1 mgCurrentUnavailableManufacturing9/07/2024
    pramipexole dihydrochloride monohydrateTablet.25 mgCurrentUnavailableManufacturing9/07/2024
    dexamethasone sodium phosphateInjection, solution4.37 mg/mLCurrentLimited AvailabilityManufacturing9/07/2024
    drospirenone~ethinylestradiolTablet3 mg~30 microgramAnticipatedAvailableManufacturing9/07/2024
    rabeprazole sodiumTablet, enteric coated20 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues9/07/2024
    zolmitriptanTablet, film coated2.5 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues9/07/2024
    OmalizumabInjection, solution150 mgCurrentUnavailableManufacturing9/07/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~5.198 mgCurrentUnavailableManufacturing9/07/2024
    quetiapine fumarateTablet, film coated28.78 mgResolvedAvailableManufacturing9/07/2024
    rizatriptan benzoateTablet, orally disintegrating14.53 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues9/07/2024
    rizatriptan benzoateTablet, orally disintegrating14.53 mgCurrentUnavailableManufacturing9/07/2024
    aciclovir sodium dihydrateInjection, powder for628.8 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply9/07/2024
    aciclovir sodium dihydrateInjection, powder for314.4 mgResolvedAvailableUnexpected increase in consumer demand9/07/2024
    metformin hydrochlorideTablet, film coated500 mgAnticipatedAvailableManufacturing9/07/2024
    gliclazideTablet, modified release30 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply9/07/2024
    estradiol~estradiol~norethisterone acetateDrug delivery system, transdermal.62 mg~.78 mg~2.7 mgResolvedAvailableManufacturing9/07/2024
    Avalglucosidase alfaInjection, powder for100 mgAnticipatedAvailableManufacturing9/07/2024
    clindamycin phosphateInjection, solution0 QSResolvedAvailableManufacturing9/07/2024
    doxycycline monohydrateTablet, uncoated104.1 mgCurrentLimited AvailabilityManufacturing9/07/2024
    disulfiramTablet, effervescent200 mgResolvedAvailableManufacturing9/07/2024
    baclofenTablet10 mgAnticipatedAvailableManufacturing9/07/2024
    metformin hydrochlorideTablet, film coated500 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues9/07/2024
    metformin hydrochlorideTablet, film coated1000 mgCurrentUnavailableManufacturing9/07/2024
    ganciclovir sodiumInjection, powder for543 mgResolvedAvailableManufacturing8/07/2024
    prazosin hydrochlorideTablet, uncoated5.476 mgCurrentUnavailableUnexpected increase in consumer demand8/07/2024
    methotrexateInjection, solution50 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability8/07/2024
    human menopausal gonadotrophinInjection, powder for600 IUCurrentLimited AvailabilityManufacturing8/07/2024
    human menopausal gonadotrophinInjection, powder for1200 IUCurrentLimited AvailabilityManufacturing8/07/2024
    ropivacaine hydrochlorideInjection, solution7.5 mg/mLResolvedAvailableManufacturing8/07/2024
    rosuvastatin calcium~ezetimibeTablet~Tablet, film coated5.198 mg~10 mgCurrentUnavailableManufacturing8/07/2024
    duloxetine hydrochlorideCapsule, enteric67.32 mgResolvedAvailableUnexpected increase in consumer demand8/07/2024
    dobutamine hydrochlorideInjection, solution14.01 mg/mLCurrentUnavailableManufacturing8/07/2024
    raltitrexedInjection, powder for2 mgCurrentLimited AvailabilityUnexpected increase in consumer demand8/07/2024
    meropenemInjection, powder for1 gDiscontinuedUnavailableCommercial Changes / Commercial viability8/07/2024
    meropenemInjection, powder for500 mgDiscontinuedUnavailableCommercial Changes / Commercial viability8/07/2024
    aciclovirInjection, solution25 mg/mLResolvedAvailableManufacturing8/07/2024

製薬会社、研究者、医療機関
の皆さまへ

賛助会員になると、さらに詳しい医薬情報の提供、共同研究、コンサルティングなど、当法人の専門的なサポートが受けられます。

このページの先頭へ戻る